Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2023 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Net Cash Flow came in at -$14597.0 in Q1 2026, down 3115.2% year-on-year from $484.11 in Q1 2025, and down 165.74% quarter-over-quarter from -$5493.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Net Cash Flow across 4 years of filings, most recently posting -$14597.0 for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$14597.0, down 3115.2% year-over-year; the trailing twelve-month figure through Feb 2026 was -$111398.0 (down 45183.74% YoY), and the FY2025 annual result was $12197.0, up 249.51% from the prior year.
- Net Cash Flow came in at -$14597.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from -$5493.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $12404.0 in Q2 2025 to a low of -$103712.0 in Q3 2025.
- The 4-year median for Net Cash Flow is -$454.0 (2025), against an average of -$10379.9.
- Peak annual rise in Net Cash Flow reached 31905.13% in 2025, while the deepest fall reached 48563.55% in 2025.
- Cannabis Bioscience International Holdings' Net Cash Flow stood at -$4410.0 in 2023, then jumped by 100.75% to $33.0 in 2024, then tumbled by 16745.45% to -$5493.0 in 2025, then sank by 165.74% to -$14597.0 in 2026.
- The last three Net Cash Flow figures came in at -$14597.0 (Q1 2026), -$5493.0 (Q4 2025), and -$103712.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -14,597.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -14,597.00 |
| Feb 28, 2026 | -14,597.00 |
| Nov 30, 2025 | -5,493.00 |
| Nov 30, 2025 | -5,493.00 |
| Aug 31, 2025 | -103,712.00 |
| Aug 31, 2025 | -103,712.00 |
| May 31, 2025 | 12,404.00 |
| May 31, 2025 | 12,404.00 |
| Feb 28, 2025 | -454.00 |
| Feb 28, 2025 | -454.00 |
| Nov 30, 2024 | 33.00 |
| Nov 30, 2024 | 33.00 |
| Aug 31, 2024 | 214.00 |
| Aug 31, 2024 | 214.00 |
| May 31, 2024 | -39.00 |
| May 31, 2024 | -39.00 |
| Feb 29, 2024 | 458.00 |
| Feb 29, 2024 | 458.00 |
| Nov 30, 2023 | -4,410.00 |
| Nov 30, 2023 | -4,410.00 |